The Efficacy of Transurethral Resection of Prostate on the Patients with Benign Prostatic Hyperplasia and Detrusor Hyperactivity with Impaired Contractility.
- Author:
Hee Joo CHO
1
;
Jea Hyung WOO
;
Jeong Yoon KANG
;
Jeong Yun JEONG
;
Tag Keun YOO
Author Information
1. Department of Urology, Eulji University School of Medicine, Eulji Medical Center, Seoul, Korea. ytk5202@eulji.or.kr
- Publication Type:Original Article
- Keywords:
Benign prostatic hyperplasia;
Detrusor hyperactivity with impaired contractility;
Transurethral resection of prostate
- MeSH:
Aged;
Cystoscopy;
Humans;
Male;
Prostate;
Prostatic Hyperplasia*;
Retrospective Studies;
Transurethral Resection of Prostate*;
Urinary Bladder Neck Obstruction;
Urodynamics
- From:Journal of the Korean Continence Society
2005;9(2):135-138
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Detrusor hyperactivity with impaired contractility(DHIC) can be found in many elderly patients with benign prostatic hyperplasia(BPH). It is hard to expect the efficacy of transurethral resection of prostate(TURP) on such patients. Therefore, we retrospectively estimated the effect of TURP on BPH patients with DHIC. MATERIALS AND METHODS: Eighteen male patients with BPH and DHIC were underwent TURP. Through urodynamic studies, DHIC was identified. Findings of bladder outlet obstruction were evaluated with TRUS and/or diagnostic cystoscopy in all patients. They were requested to go through uroflowmetry and international prostate symptom score(IPSS), before and after TURP. The subjective satisfaction scale was measured after TURP. RESULTS: Total IPSS(from 20.6 to 12.5), obstructive symptom score(from 11.5 to 6.0), and maximal flow rate (from 6.0 ml/sec to 14.6 ml/sec) of the patients were improved significantly(p<0.05) after TURP. Storage symptom score(from 9.0 to 6.3) got better, but the improvement was not statistically significant(p>0.05). Only 2(12%) of the patients were unsatisfied with the outcomes of TURP. CONCLUSION: We suggest that TURP can be used as a good therapeutic option for selected patients with BPH accompanied with DHIC.
